Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
interferon alpha-2b (Intron-A) (1 trial)
ruxolitinib (jakafi) (2 trials)
Primary Myelofibrosis (Phase 2)
Trials (2 total)
Trial APIs (2 total)